Can bright light and better sleep beat baby blues? new trial tests Drug-Free fix for perinatal depression

NCT ID NCT04364646

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a non-drug treatment called Personalized Integrated Chronotherapy (PIC) for depression during pregnancy and after childbirth. 120 pregnant women with major depression were randomly assigned to receive either usual care (medication or therapy) or PIC plus usual care. PIC combines morning bright light therapy with personalized sleep scheduling to reset the body's internal clock. The goal was to see if this approach could reduce depressive symptoms more than standard care alone.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Personalized Integrated Chronotherapy (bright light therapy, sleep schedule adjustments)
What this could lead to
If it works, this could offer a safe, non-drug option to treat depression during and after pregnancy, improving outcomes for mothers and babies.
What could go wrong
This is a relatively small, early-stage trial (120 participants) and the therapy requires strict adherence to sleep schedules, which may be hard for new mothers. Results may not apply to all.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CIRCADIAN DYSREGULATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Feinstein Institute For Medical Research

    Glen Oaks, New York, 11004, United States

  • Rhode Island Hospital

    Providence, Rhode Island, 02903, United States

  • University of North Carolina

    Chapel Hill, North Carolina, 27599, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.